Research map: India’s challenges in regulating unproven stem cell interventions: Recommendations to strengthen adverse event reporting

Back to the article

Papers in this map

  1. Immunogenicity of induced pluripotent stem cells · Tongbiao Zhao · 2011 · 1451 citations · Cited by this paper
  2. Knowledge, attitude, and practice of informed consent among medical undergraduates: A cross-sectional study · 2026 · Related
  3. Donor-Derived Brain Tumor Following Neural Stem Cell Transplantation in an Ataxia Telangiectasia Patient · Ninette Amariglio · 2009 · 940 citations · Cited by this paper
  4. Qualitative research – Part 1 · 2026 · Related
  5. Ethical Issues in Stem Cell Research · Bernard Lo · 2009 · 632 citations · Cited by this paper
  6. Building bridges in decentralized clinical trials: A qualitative exploration of stakeholder collaboration and implementation strategies · 2026 · Related
  7. Vision Loss after Intravitreal Injection of Autologous “Stem Cells” for AMD · Ajay E. Kuriyan · 2017 · 465 citations · Cited by this paper
  8. Preventability, predictability, severity, and causality analysis of serious adverse events reported to the institute ethics committee of a tertiary health care center in central India: A retrospective study · 2026 · Related
  9. Angiomyeloproliferative Lesions Following Autologous Stem Cell Therapy · Duangpen Thirabanjasak · 2010 · 208 citations · Cited by this paper
  10. Efficacy and safety of topical phenytoin cream in diabetic foot ulcers: A randomized, open-label, parallel, and proof-of-concept study · 2025 · Related
  11. Ten years of progress and promise of induced pluripotent stem cells: historical origins, characteristics, mechanisms, limitations, and potential applications · Adekunle Ebenezer Omole · 2018 · 208 citations · Cited by this paper
  12. Beyond consent: Reframing ethical governance in genetic data reuse within clinical trials · 2026 · Related
  13. Autograft-derived spinal cord mass following olfactory mucosal cell transplantation in a spinal cord injury patient · Brian J. Dlouhy · 2014 · 183 citations · Cited by this paper
  14. Quality of life in tuberculosis patients: A comparative study of video-observed therapy and directly observed therapy · 2025 · Related
  15. Glioproliferative Lesion of the Spinal Cord as a Complication of “Stem-Cell Tourism” · Aaron L. Berkowitz · 2016 · 169 citations · Cited by this paper
  16. Use of digital healthcare technology in clinical research in the Indian setting: Opportunities and challenges · 2026 · Related
  17. Concise Review: A Comprehensive Analysis of Reported Adverse Events in Patients Receiving Unproven Stem Cell-Based Interventions · Gerhard Bauer · 2018 · 164 citations · Cited by this paper
  18. Ozenoxacin 1% versus mupirocin 2% for topical treatment of impetigo and other uncomplicated skin infections: A randomized controlled trial · 2026 · Related
  19. Under-reporting of adverse drug reactions: A challenge for pharmacovigilance in India · VishalR Tandon · 2015 · 150 citations · Cited by this paper
  20. Thromboembolism Induced by Umbilical Cord Mesenchymal Stem Cell Infusion: A Report of Two Cases and Literature Review · Zhixian Wu · 2017 · 125 citations · Cited by this paper
  21. Evaluation of awareness about pharmacovigilance and adverse drug reaction monitoring in resident doctors of a tertiary care teaching hospital · SonaliA Pimpalkhute · 2012 · 70 citations · Cited by this paper
  22. Mesenchymal stem cell therapy in severe COVID-19: A retrospective study of short-term treatment efficacy and side effects · Xian Chen · 2020 · 63 citations · Cited by this paper
  23. International Stem Cell Tourism and the Need for Effective Regulation: Part I: Stem Cell Tourism in Russia and India: Clinical Research, Innovative Treatment, or Unproven Hype? · Cynthia B. Cohen · 2010 · 61 citations · Cited by this paper
  24. Catastrophic Demyelinating Encephalomyelitis After Intrathecal and Intravenous Stem Cell Transplantation in a Patient With Multiple Sclerosis · Yazan J. Alderazi · 2011 · 39 citations · Cited by this paper
  25. Unproven Stem Cell Therapies in India: Regulatory Challenges and Proposed Paths Forward · Shashank Shekhar Tiwari · 2018 · 36 citations · Cited by this paper
  26. Stem Cell Therapy: Challenges Ahead · Satyakam Bhagavati · 2014 · 25 citations · Cited by this paper
  27. The Case for Stem Cell Counselors · Christopher Thomas Scott · 2014 · 21 citations · Cited by this paper
  28. Recent Court Ruling in Japan Exemplifies Another Layer of Regulation for Regenerative Therapy · Tsunakuni Ikka · 2015 · 16 citations · Cited by this paper
  29. Adverse Drug Reaction reporting among medical and dental practitioners: a KAP study · Shubha Praveen · 2012 · 16 citations · Cited by this paper
  30. Modulating immune responses for enhanced cell therapies: The dual role of multi-scale biomaterials · Jia'nan Zeng · 2024 · 14 citations · Cited by this paper
  31. Ventricular fibrillation following autologous intramyocardial cell therapy for inherited cardiomyopathy · Peter Pytel · 2008 · 11 citations · Cited by this paper
  32. The evolution and ongoing challenge of unproven cell-based interventions · Taylor N Brinsfield · 2024 · 11 citations · Cited by this paper
  33. Hypoimmunogenic Human iPSCs for Repair and Regeneration in the CNS · Haiwei Zhang · 2025 · 10 citations · Cited by this paper
  34. Awareness among tertiary care doctors about Pharmacovigilance Programme of India: Do endocrinologists differ from others? · Pramod Kumar Sharma · 2016 · 7 citations · Cited by this paper
  35. Adverse Events Related to Unapproved Stem Cell Products and Other Regenerative Interventions: Recommendations for More Robust Regulation of the Direct-To-Consumer Marketplace · Farzana Akkas · 2021 · 6 citations · Cited by this paper
  36. Commentary on “Possible induction of acute disseminated encephalomyelitis (ADEM)-like demyelinating illness by intrathecal mesenchymal stem cell injection” · Helmut Butzkueven · 2012 · 5 citations · Cited by this paper
  37. A comprehensive review of challenges and opportunities for stem cell research in India · Kavita Srivastava · 2024 · 3 citations · Cited by this paper
  38. The Indian regulatory framework and the surge of unproven stem cell therapies—a call for diagnosis · Vaishnav M · 2025 · 2 citations · Cited by this paper
  39. Stem cell therapy approaches for non-malignant diseases & non-haematological diseases in India: A systematic review · Chandrashekhar Chavan · 2024 · 1 citation · Cited by this paper

Source: OpenAlex (CC0)